// startup autopsy

Quantuvis

Pharmaceutical contract SaaS that ran out of runway before closing its first big deals.

marketfitSlow Death

Years-long decline before final shutdown · Fatal mistake: Quantuvis underestimated the capital and time required to navigate enterprise pharmaceutical sales cycles with a seed-stage budget.

Founded	2013
Closed	2016
Country	USA
Sector	Saas

50%

Key Events Timeline

2013-01-01

FOUNDING

Quantuvis founded to build SaaS solutions for pharmaceutical contract management.

2014-06-01

FUNDING

Raised $1.40397M in seed funding to develop and market its pharma contract platform.

2015-03-01

PRODUCT LAUNCH

Launched platform to enterprise pharmaceutical clients but faced slow adoption due to lengthy procurement cycles.

2016-06-01

SHUTDOWN

Quantuvis ceased operations after exhausting its seed capital without securing sufficient recurring revenue.

Full Analysis

Analyst plan

Documented cause

Quantuvis built a SaaS platform targeting pharmaceutical contract management, operating in a heavily regulated and relationship-driven industry. The company raised only $1.4M in funding with its last capital in...

jection occurring in 2014, which proved insufficient to sustain operations through the extended sales cycles required in enterprise pharmaceutical procurement. The startup struggled to gain meaningful

Verified lesson

“...”

Unlock full lesson →

€1.7M

Peak valuation

HypeCycle · MoatType · ResearchTags

Quantuvis raised €1.40397M before quantuvis underestimated the capital and time required to navigate enterprise pharmaceutical sales cycles with a seed-stage budget. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo